Ivermectin vs. Merck's New Antiviral, Molnupiravir
Based on Merck's data, a comparison between molnupiravir and ivermectin yields interesting results. Consider other nonprescription strategies for prevention and early treatment.
Keep reading with a 7-day free trial
Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.